Global Assisted Reproductive Technology Market was worth $28.2 billion USD in 2021. AMR Group projects that the market will reach US$ 42.8 billion by 2031, growing at a CAGR of 8.9 percent between 2022 and 2031.
Industry Overview
Assisted Reproductive Technology (ART) refers to medical procedures that assist in the conception of a child by means other than sexual intercourse.
ART involves various techniques that help individuals or couples achieve pregnancy when they are facing fertility problems or difficulties conceiving naturally.
There are several types of ART, including: In vitro fertilization (IVF): In IVF, eggs are surgically retrieved from a woman’s ovaries and fertilized with sperm in a laboratory. The resulting embryos are then transferred to the woman’s uterus.
Intracytoplasmic sperm injection (ICSI): In ICSI, a single sperm is directly injected into an egg in a laboratory. The fertilized egg is then transferred to the woman’s uterus.
Gamete intrafallopian transfer (GIFT): In GIFT, eggs are retrieved from a woman’s ovaries and mixed with sperm in a laboratory. The mixture is then injected into the woman’s fallopian tubes, where fertilization occurs naturally.
Request Free Sample Report: https://analyticsmarketresearch.com/sample-request/assisted-reproductive-technology-market/76762/
Zygote intrafallopian transfer (ZIFT): In ZIFT, fertilized eggs (zygotes) are transferred to the woman’s fallopian tubes instead of the uterus.
Donor eggs or sperm: In some cases, individuals or couples may use donated eggs or sperm to achieve pregnancy. ART is a rapidly evolving field, and new techniques are being developed and refined to improve success rates and reduce risks and complications. ART can be expensive, and success rates can vary depending on factors such as age, underlying health conditions, and the specific technique used..
Market Dynamics
The global assisted reproductive technology (ART) market is driven by various factors, including the increasing prevalence of infertility and advancements in medical technology. Here are some of the key market dynamics for ART: Increasing Prevalence of Infertility: The incidence of infertility is increasing globally due to various factors such as lifestyle changes, stress, obesity, and rising maternal age. According to the World Health Organization (WHO), infertility affects approximately 10-15% of couples worldwide. This has led to an increased demand for ART services.
Advancements in Medical Technology: The ART market has been driven by advancements in medical technology, including improvements in laboratory techniques, genetic screening, and cryopreservation. These advancements have led to higher success rates and lower risks and complications associated with ART procedures. Growing Demand for Surrogacy Services: The growing acceptance of surrogacy as a viable option for couples who cannot conceive naturally has led to an increase in demand for ART services, including IVF and ICSI. Legal and Ethical Issues: The ART market is also impacted by legal and ethical issues related to the use of donor eggs and sperm, surrogacy, and the creation and storage of embryos.
These issues can vary by country and can impact the availability and use of ART services.
Cost of ART Procedures: The cost of ART procedures can be high and may not be covered by insurance in some countries. This can limit access to ART services, particularly for individuals with lower incomes.
Overall, the ART market is expected to continue to grow due to increasing demand for infertility treatment, advancements in medical technology, and growing acceptance of surrogacy services. However, legal and ethical issues, as well as the cost of ART procedures, may continue to impact the availability and use of ART services.
COVID Impact:
The COVID-19 pandemic has had a significant impact on the assisted reproductive technology (ART) market. Here are some of the key effects of the pandemic on the ART market Disruptions in Service Provision: The COVID-19 pandemic has resulted in disruptions in ART services, including clinic closures, reduced capacity, and cancelled appointments. This has led to delays in treatment and reduced access to ART services for some individuals and couples.
Financial Impact: The pandemic has resulted in economic uncertainty and financial strain for many individuals and families, which has led to a reduction in demand for ART services due to the high cost of treatment.
Health Concerns: The COVID-19 pandemic has raised concerns about the safety of individuals seeking ART services, particularly those with underlying health conditions that may increase their risk of severe illness from COVID-19. This has led to some individuals and couples delaying or cancelling ART treatment.
Impact on Donor Availability: The pandemic has also impacted the availability of donor eggs and sperm, as some donors may be unable or unwilling to donate due to health concerns or travel restrictions.
Changes in Clinic Protocols: Many clinics have had to implement new protocols and safety measures to reduce the risk of COVID-19 transmission, such as requiring masks, conducting screening tests, and limiting the number of individuals in waiting rooms. These changes may impact the patient experience and may result in longer wait times and reduced capacity. Overall, the COVID-19 pandemic has had a significant impact on the ART market, with disruptions in service provision, financial strain, health concerns, and changes in clinic protocols. However, as the pandemic situation improves, it is expected that demand for ART services will increase once again, particularly as individuals and couples seek to address delayed fertility treatments.
Regional Trend
The demand for assisted reproductive technology (ART) services varies by region, with some regions experiencing higher demand than others. Here is a regional analysis of the ART market:
North America: North America is the largest market for ART services, accounting for the majority of the global market share. This is due to the high prevalence of infertility in the region, as well as the availability of advanced medical technology and supportive government policies.
Europe: Europe is another major market for ART services, with countries such as the UK, Spain, and France being popular destinations for international patients seeking treatment. The region also has a well-established regulatory framework for ART services, which has helped to ensure the safety and efficacy of these treatments.
Asia-Pacific: The Asia-Pacific region is expected to experience significant growth in the ART market due to factors such as increasing awareness of infertility, rising disposable incomes, and improvements in healthcare infrastructure. China is the largest market for ART services in the region, followed by India and Japan.
Latin America: The Latin America market for ART services is also growing, with countries such as Brazil and Mexico experiencing increasing demand for these treatments. However, the high cost of ART services can limit access to these treatments for some individuals and couples in the region.
Middle East and Africa: The Middle East and Africa region has a smaller market share for ART services compared to other regions, due in part to cultural and religious factors that can impact the acceptability of these treatments. However, the region is expected to experience some growth in the ART market in the coming years, particularly as access to healthcare improves.
Read This Complete Strategic Report: https://analyticsmarketresearch.com/reports/assisted-reproductive-technology-market/76762/
Competitive Landscape
The global market for assisted reproductive technology (ART) is highly competitive, with a large number of players operating in the market. Here are some of the key players in the ART market:
Merck & Co., Inc.: Merck is a leading player in the ART market, offering a range of fertility drugs and hormones that are used in ART treatments.
Vitrolife AB: Vitrolife is a Swedish company that specializes in products for the preparation and handling of human gametes and embryos. Its product portfolio includes media, devices, and systems for ART treatments.
CooperSurgical, Inc.: CooperSurgical is a global provider of medical devices and fertility products, including products for ART treatments such as IVF and ICSI.
Ferring Pharmaceuticals: Ferring is a Swiss company that offers a range of fertility products and treatments, including ART products and hormone therapies.
Irvine Scientific: Irvine Scientific is a California-based company that provides advanced cell culture media and services for ART treatments and other medical applications.
Boston IVF: Boston IVF is a leading provider of ART services in the United States, offering a range of treatments such as IVF, ICSI, and egg donation.
Genea: Genea is an Australian company that specializes in fertility treatments and technologies, including ART treatments and pre-implantation genetic testing.
Cook Medical: Cook Medical is a global medical device company that offers a range of products for reproductive health, including ART products and technologies.
OvaScience: OvaScience is a biotechnology company that focuses on developing treatments for infertility and other reproductive health conditions, including ART treatments.
Progyny: Progyny is a fertility benefits management company that provides a range of fertility services and technologies, including ART treatments and fertility medications.
Overall, the ART market is highly competitive, with a large number of players operating in the market, offering a range of products and services for ART treatments.
Market Segmentation
The market for assisted reproductive technology (ART) can be segmented on the basis of type of procedure, end-user, and region. Here is a brief overview of each of these segments:
Type of Procedure: The ART market can be segmented based on the type of procedure, including in vitro fertilization (IVF), intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI), and others. IVF is the most commonly used ART procedure and accounts for the largest share of the market.
End-user: The ART market can also be segmented based on the end-user, including fertility clinics, hospitals, and others. Fertility clinics are the largest end-users of ART services, as they are specialized facilities that provide comprehensive ART treatments and services.
Region: The ART market can also be segmented based on geography, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America and Europe are the largest markets for ART services, while the Asia-Pacific region is expected to experience significant growth in the coming years.
Other factors that can impact market segmentation include age, gender, and underlying medical conditions of patients seeking ART treatments. For example, women over the age of 35 may require different types of ART treatments than younger women due to decreased fertility, while male infertility may require specialized treatments such as ICSI.
Read Our More Blogs: https://www.linkedin.com/pulse/what-honeysuckle-berries-extract-good-anamika-tawar
